(Date:12/1/2008)...stress disorder (PTSD) affects as many as one in f...ience like rape, assault, war or terrorism. It has...n up survivors, families. , There is no broadly...eveloping the disorder, but thanks to a Tel Aviv U...g PTSD may be just around the corner. , Prof. Jo...
(Date:12/1/2008)...Newswire/ -- Blue Cross Blue Shield of Michigan,p...and membership information,today to Michigan Atto...rther,information about Michigan,s individual hea...rowth of Michigan,s individual health insurance ma...BCBSM, the state,s last-resort,insurance carrier,...
(Date:12/1/2008).... 1 Seniors who take a close look ...dvantage plans may still realize,savings next yea...ill continue,to offer $0 monthly premiums and $0 ..."gap" or "donut hole" (when beneficiaries pay 100%...-of-pocket costs). HealthMetrix,Research Inc. sc...
(Date:12/1/2008)...RNewswire/ -- Amanzi Tea ( www.amanzitea.com ), a ...in celebration of its first Manhattan location ope...amanzi tea flu shots" made of double strength, fre...13th and 20th from noon until four. This is a hea...with the onset of winter. , , In a recent...
Breaking Medicine News(10 mins):Health News:Easing the stress of trauma 2Health News:Blue Cross Blue Shield of Michigan Answers Attorney General 2Health News:Blue Cross Blue Shield of Michigan Answers Attorney General 3Health News:HealthMetrix Research Finds Medicare Advantage Plans Offer Seniors Opportunity to Lower Their 2009 Out-of-Pocket Drug Costs 2Health News:Amanzi Tea offers free, natural 'Flu Shots' to New Yorkers 2(Date:12/1/2008)...YMOUTH MEETING, Pa., Dec. 1 /PRNewswire-FirstCall/...nnounced that dosing of subjects has begun in stud...g dose Phase 1b study of trodusquemine (MSI-1436) ... is a novel therapeutic for the treatment of type ...eripherally to regulate insulin and leptin pathway...
(Date:12/1/2008)...LANTA, Dec. 1 GeoVax Lab...sed biotechnology company developing,human vaccin...iency Virus) and,other infectious agents, announc...ccine Trials will take place in twelve sites acros...cted in collaboration with The National Institutes...
(Date:11/30/2008)...ICAGO, Dec. 1 Abnormali...aluated in children with autism spectrum disorder ...o a study presented today at the annual meeting of... , , "Using MEG, we can record the tiny mag...vity," said Timothy Roberts, Ph.D., vice chair of ...
(Date:11/27/2008)...w study finds the majority of acute lymphoblastic ...resent at the time of diagnosis , , MEMPHIS...ists at St. Jude Children,s Research Hospital have...cer cells of children with acute lymphoblastic leu... a pathway to designing treatments for ALL relapse...
Breaking Medicine Technology:Genaera Begins Phase 1b Trial of Trodusquemine (MSI-1436) in Overweight and Obese Type 2 Diabetics 2Genaera Begins Phase 1b Trial of Trodusquemine (MSI-1436) in Overweight and Obese Type 2 Diabetics 3GeoVax's Phase 2a HIV/AIDS Vaccine Human Trials to Begin in North and South America 2GeoVax's Phase 2a HIV/AIDS Vaccine Human Trials to Begin in North and South America 3Brain Waves Show Sound Processing Abnormalities in Autistic Children 2Brain Waves Show Sound Processing Abnormalities in Autistic Children 3St. Jude Identifies Genomic Causes of a Certain Type of Leukemia Relapse 2St. Jude Identifies Genomic Causes of a Certain Type of Leukemia Relapse 3Cell surface sugar defects may trigger nerve damage in multiple sclerosis patients 1688 1Cell surface sugar defects may trigger nerve damage in multiple sclerosis patients 1688 2UCSD study reveals the regulatory mechanism of key enzyme 1684 1UCSD study reveals the regulatory mechanism of key enzyme 1684 2Controlling for size may also prevent cancer 473 1Controlling for size may also prevent cancer 473 2PSI Brings its Pioneering Efforts to a Close 1677 1PSI Brings its Pioneering Efforts to a Close 1677 2PSI Brings its Pioneering Efforts to a Close 1677 3...9, 2007 - IgG1 monoclonal,antibodies developed by ...he focus of 44 total presentations at the recently...ociation for Cancer Research,(AACR), including sev...RBITUX(R) (cetuximab) clinical data were the focus...f the "Breakthroughs,in Clinical Research" Plenary...
... LAUSANNE, Switzerland, April 19, 2007 /PRNewswire...endent biopharmaceutical,development specialist in...d additional results of a previous phase Ib, 15 da... in HIV/HCV (hepatitis C,virus) co-infected patien...ting of the European Association for the Study of ...
Other Medicine Technology:ImClone Systems Showcases Extensive Research and Development,Program at the AACR Annual Meeting 2ImClone Systems Showcases Extensive Research and Development,Program at the AACR Annual Meeting 3ImClone Systems Showcases Extensive Research and Development,Program at the AACR Annual Meeting 4ImClone Systems Showcases Extensive Research and Development,Program at the AACR Annual Meeting 5Clinical Update - Debio 025 Cyclophilin Inhibitor for the Treatment,of HCV 2Clinical Update - Debio 025 Cyclophilin Inhibitor for the Treatment,of HCV 3Clinical Update - Debio 025 Cyclophilin Inhibitor for the Treatment,of HCV 4...ur breadth of infectious disease ELISA products ma...protocols for faster integration into the busy lab...vide increased reliability and run-to-run consiste...tibody detection assays for a wide range of serolo...
...ur breadth of infectious disease ELISA products ma...protocols for faster integration into the busy lab...vide increased reliability and run-to-run consiste...tibody detection assays for a wide range of serolo...
...ur breadth of infectious disease ELISA products ma...protocols for faster integration into the busy lab...vide increased reliability and run-to-run consiste...tibody detection assays for a wide range of serolo...
...ur breadth of infectious disease ELISA products ma...protocols for faster integration into the busy lab...vide increased reliability and run-to-run consiste...tibody detection assays for a wide range of serolo...
Medicine Products: